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Background: Esophageal resection is associated with a high incidence of postoperative pneumonia. Respiratory
complications account for almost half of the readmissions to the critical care unit. Postoperative complications can
result in prolonged hospital stay and consequently increase healthcare costs. In cardiac surgery a preoperative
inspiratory muscle training program has shown to prevent postoperative pneumonia and reduce length of hospital
stay. While in some surgical centers inspiratory muscle training is already used in the preoperative phase in patients
undergoing esophageal resection, the added value of this intervention on the reduction of pulmonary
complications has not yet been investigated in large surgical populations other than cardiac surgery in a
randomized and controlled study design.
Methods/Design: The effect of a preoperative inspiratory muscle training program on the incidence of
postoperative pneumonia in patients undergoing esophageal resection will be studied in a single blind multicenter
randomized controlled trial (the PREPARE study). In total 248 patients (age >18 years) undergoing esophageal
resection for esophageal cancer will be included in this study. They are randomized to either usual care or usual care
with an additional inspiratory muscle training intervention according to a high-intensity protocol which is performed
with a tapered flow resistive inspiratory loading device. Patients have to complete 30 dynamic inspiratory efforts twice
daily for 7 days a week until surgery with a minimum of 2 weeks. The starting training load will be aimed to be 60% of
maximal inspiratory pressure and will be increased based on the rate of perceived exertion.
The main study endpoint is the incidence of postoperative pneumonia. Secondary objectives are to evaluate the effect
of preoperative inspiratory muscle training on length of hospital stay, duration of mechanical ventilation, incidence of
other postoperative (pulmonary) complications, quality of life, and on postoperative respiratory muscle function and
lung function.
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Discussion: The PREPARE study is the first multicenter randomized controlled trial to evaluate the hypothesis that
preoperative inspiratory muscle training leads to decreased pulmonary complications in patients undergoing
esophageal resection.
Trial registration: NCT01893008.
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The numbers of esophageal cancer patients are increas-
ing worldwide. The incidence of esophageal cancer is
increased by 50% in the past two decades [1]. Surgical
resection, mostly preceded by neoadjuvant chemoradio-
therapy, is regarded the only curable option for esopha-
geal cancer [2]. While the in-hospital mortality rate is
below 5% after this surgery, several studies report in-
hospital postoperative pneumonia rates around 30% [2-4].
Respiratory complications account for almost half of the
readmissions to critical care units [5] and the development
of pneumonia is associated with a mortality of 20% com-
pared with 3% among patients free of pneumonia [6].
Besides increased mortality, the high rate of pneumonia re-
sults in increased length of stay in the intensive care unit
(ICU) and in the hospital [7,8] which results in increased
and prolonged use of medical care, with subsequent conse-
quences for healthcare costs. Therefore, preventing pneu-
monia is better than curing pneumonia.
Several factors associated with esophageal resection,
such as diaphragmatic dysfunction as a result of intra-
thoracic manipulation of tissue, perioperative lung col-
lapse, mechanical ventilation, and supine positioning, can
increase perioperative ventilatory demand [9]. When the
ventilatory demand (or workload) exceeds the ventilatory
capacity (or ability), this imbalance can lead to ventilatory
pump failure. Following, ventilatory pump failure can re-
sult in alveolar hypoventilation which may progress to re-
spiratory failure, pneumonia, or even death [9].
Physical therapy interventions to prevent pneumonia
and other postoperative pulmonary complications (PPCs)
often focus on postoperative prophylaxis using various re-
spiratory techniques and devices [10-12]. A relatively new
physical therapy intervention to prevent PPCs and pneu-
monia is preoperative inspiratory muscle training (IMT).
IMT is performed with an inspiratory loading device and
results in increased strength and endurance of the inspira-
tory muscles [13-15]. Since the ventilatory capacity partly
depends on optimal respiratory muscle performance, in-
creased inspiratory muscle function may lead to improved
ventilatory capacity [9]. The hypothesis is that when IMT
is applied in the preoperative phase of esophageal resec-
tion it may prevent the imbalance between ventilatory
demand and ventilatory capacity resulting in a reduc-
tion of PPCs.A large randomized controlled trial (RCT) found that
IMT before coronary bypass surgery significantly reduced
PPCs and length of hospital stay. PPCs, including pneu-
monia, were reduced by over 50% in patients at high risk
of developing pulmonary complications [13]. In abdom-
inal surgery beneficiary effects are reported on the inci-
dence of atelectasis [16].
While in some surgical centers IMT is already used in
the preoperative phase in patients undergoing esopha-
geal resection, the effect of this intervention has not yet
been investigated in a randomized controlled study in
large surgical populations other than cardiac surgery.
One non-randomized pilot study concluded that IMT is
feasible and well tolerated before esophageal resection
but did not show an effect on postoperative pulmonary
outcome or length of hospital stay [15].
This article provides a detailed description of the back-
ground, the targeted population, and study methodology
of the PREPARE study (preoperative inspiratory muscle
training to prevent postoperative pneumonia in patients
undergoing esophageal resection), a multicenter RCT in-
vestigating the effect of preoperative IMT in esophageal
resection candidates.
Methods/Design
Study objectives
The primary objective is to evaluate the effect of pre-
operative IMT in addition to usual care, compared to
usual care without IMT, in patients undergoing esopha-
geal resection on the incidence of postoperative pneu-
monia. Secondary objectives are to evaluate the effect of
preoperative inspiratory muscle training on length of
hospital stay, duration of mechanical ventilation, inci-
dence of other postoperative (pulmonary) complications,
quality of life, and on postoperative respiratory muscle
function and lung function.
Study design and setting
This study is conducted as a single-blind multicenter
RCT and will be coordinated by the University Medical
Center Utrecht (UMCU) (Department of Rehabilitation,
Nursing Science & Sports and Department of Surgery).
Patients are randomly assigned to either care as usual
without IMT or to IMT as an addition to care as usual.
The randomization procedure is performed by a flexible
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quence will be concealed. Randomization is stratified
by center and minimization techniques are applied for
surgical technique (transhiatal esophageal resection, trans-
thoracic esophageal resection, minimally invasive esopha-
geal resection).
This study is funded by ‘NutsOhra Foundation’ and
‘The Friends of the UMC Utrecht Foundation’, and will
be conducted in accordance with the principles of the
Declaration of Helsinki and Good Clinical Practice Guide-
lines. The independent ethics committee of the UMCU
has approved the study. Written informed consent will be
obtained from all participating patients.
Study population
All patients diagnosed with esophageal cancer and sched-
uled for esophageal resection with gastric conduit re-
construction by either a transhiatal esophageal resection
(THE), a transthoracic esophageal resection (TTE), or min-
imally invasive (robot-assisted or conventional) thoraco-
laparoscopic esophageal resection (MIE) are considered
eligible for inclusion.
Further inclusion criteria are: (1) the patient is (cogni-
tively) capable to understand and perform a preoperative
IMT program; (2) the operation is scheduled at least
2 weeks after signing informed consent, since the pa-
tients need to be able to follow the intervention program
for at least 2 weeks; and (3) the patient is willing to sign
the informed consent form.
Patient are excluded based on the following criteria:
(1) the patient is unable to communicate in the Dutch
language; (2) age <18 years; and (3) the patient is participat-
ing in a conflicting trial concerning esophageal resection.
Recruitment and informed consent
Patients are recruited from eight esophageal resection
hospitals (in The Netherlands: Atrium Medical Center
Heerlen, Canisius Wilhelmina Hospital Nijmegen, Reinier
de Graaf Group Delft, University Medical Center Utrecht,
VU Medical Center Amsterdam, Hospital Group Twente
Almelo; in Belgium: University Hospital Gasthuisberg
Leuven; and in Ireland: St. James’s Hospital Dublin). In
every participating center one oncological surgeon and
one physical therapist (PT) are the contact people for the
coordinating researcher. Inclusion takes place for a period
of approximately 1 year (September 2013 to August 2014).
The local oncological surgeon determines whether a pa-
tient is eligible for inclusion in the PREPARE trial based
on the inclusion criteria. At the start of the chemoradia-
tion period or at the time the patient is informed about
the planned surgery (when chemoradiation is not indi-
cated), the surgeon informs the patient about the trial and
hands over the trial information letter. After at least 5 days
the patient is contacted by phone. When the patient ismotivated to participate, an appointment with the local
assessor is scheduled (after the chemoradiation period) for
signing the informed consent form and completing the
baseline measurements. The baseline measurement is
followed by randomization, and the IMT instruction for
patients in the intervention group. Both performed by the
involved PT.
Baseline assessment and follow-up measurements
The patient characteristics age, weight, height, gender,
daily work, highest education, civil status, and preopera-
tive physical therapy guidance (outside trial context) are
prospectively recorded by means of a standardized inter-
view during the baseline assessment. Data obtained from
the patients’ medical records include history of COPD,
smoking, pneumonia, diabetes mellitus, productive cough
and cardiac events, tumor location, neoadjuvant treat-
ment, prophylactic antibiotics, American Society of Anes-
thesiologists (ASA) score, admission and discharges dates,
operation technique.
To evaluate the effect of IMT on respiratory muscle func-
tion and lung function, participants undergo measurements
at five time points (baseline (T0), the day before surgery
(T1), and during hospital stay on postoperative day 3 (T2),
day 6 (T3), and day 9 (T4)). To determine an effect of IMT
on quality of life (QoL) the EuroQol-5D and the SF-12 are
assessed at baseline and 4 weeks after surgery. See for
detailed description the paragraph secondary endpoints.
Usual care
Surgical usual care in all Dutch centers consists of 5 to
6 weeks of preoperative chemoradiotherapy according to
the CROSS group protocol [2]. In the centers in Belgium
and Ireland, a different chemoradiotherapy schedule is
used which is indicated on the tumor stage. The chemo-
radiotherapy schedule is followed by a recovery period of
4 to 8 weeks, depending on the recovery of the patient
and waiting time for surgery per center. Patients not re-
ceiving chemoradiotherapy, will be placed on a waiting list
for surgery which is in general at least 4 weeks. Physical
therapy usual care in the preoperative phase can consist of
‘a preoperative instruction about postoperative physical
therapy involvement’, ‘preoperative advice to stay active or
seek training guidance’, ‘preoperative exercise guidance’,
or ‘no involvement until surgery’. Centers where preopera-
tive IMT is currently part of usual care for all or a selected
group of patients adapt to the PREPARE protocol and re-
lease IMT from their usual care. Patients assigned to the
control group will only receive usual care.
Postoperatively physical therapy involvement can con-
sist of respiratory physical therapy and physical therapy to
facilitate early mobilization and independent functioning
in activities of daily living. The differences in usual care
per center is carefully registered.
Table 1 The Utrecht Pneumonia scoring system [22]
Diagnostic determinant Values Score
Temperature (°C) ≥ 36.1 and ≤ 38.4 0
≥ 38.5 and ≤ 38.9 1
≥ 39.0 and ≤ 36.0 2
Leukocyte count [×109/L] ≥ 4.0 and ≤ 11.0 0
< 4.0 or > 11.0 1
Pulmonary radiography No infiltrate 0
Diffused (or patchy) infiltrate 1
Well-circumscribed infiltrate 2
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Patients included in the intervention group receive an
IMT program as an addition to usual care, starting in
the recovery period after chemoradiotherapy. Patients
not receiving chemoradiotherapy, start with the IMT
program during the waiting period before surgery. IMT
instructions are given by a specially instructed PT. The
intervention used in this study entails the use of a tapered
flow resistive inspiratory loading device: the POWER-
breathe K3-series, an electronic IMT, and monitoring
system [17]. It allows storing the data of the unsupervised
training sessions to control compliance with the treatment.
The IMT intervention is based on the protocol of Bailey
et al. [18]. This protocol is tailored individually. Starting
inspiratory load is aimed at 60% of the measured maximal
inspiratory pressure (Pimax). The load is incrementally in-
creased based on the rate of perceived exertion (RPE)
scored on a scale from 0 to 10 which is scored by the pa-
tient after each training session [19,20]. When patients
score an RPE below 7, the inspiratory load of the threshold
device will be increased with 5% by the patient. Patients
have to complete 30 dynamic inspiratory efforts twice daily.
All patients in the intervention group are instructed
during a face-to-face instruction session, will train at
home 7 days a week for at least 2 weeks and continue
training until surgery. Additionally, patients receive an
instruction movie to watch at home and a training diary
where the use of the inspiratory muscle trainer is illus-
trated step by step. Training results (RPE, level, load,
power, volume, t-index) are recorded by the patients in
the training diary after each training session. After the
instruction session, the PT contacts the patient by phone
after 3 days. When the training is not performed as
instructed, the PT makes a follow-up appointment with
the patient to repeat the instruction. Subsequently, train-
ing progress is evaluated during a weekly telephone con-
sultation by the PT until surgery. At the end of the
training period, IMT will be evaluated with a question-
naire. All involved PTs guiding patients during the IMT
period received education and training during a meeting
on the theory and practice of IMT organized by the re-
search group.
Blinding
The PREPARE study is a single blind randomized con-
trolled trial. The local assessors (performing the informed
consent procedure and the baseline and follow-up mea-
surements), the surgeons, and other medical staff are
blinded for group allocation. The patient and the PT (per-
forming the randomization and guiding the intervention
group) are not blinded for group allocation.
Patients in both groups will be informed that the
PREPARE study aims to investigate the effect of a pre-
operative (home-based) IMT program on the reduction ofpostoperative pneumonia. The intervention group add-
itionally receives detailed information about the interven-
tion like timing, frequency, and intensity of the training.
Included patients will not have contact with each other
within the context of this trial.
Primary endpoint
The primary outcome of the study is the incidence of
postoperative pneumonia, as this is the most frequently
occurring complication after esophageal resection and is
an important cause of increased morbidity and mortality
[6,21]. Pneumonia is defined according to the definition
of the Utrecht Pneumonia Scoring System (UPSS) [22].
The UPSS corresponds with the clinical practice proce-
dures for diagnosing pneumonia. Temperature, leukocyte
count, and chest radiography are determinants that can
objectively be assessed to diagnose pneumonia.
A score of 2 points or more (with at least 1 point
assigned based on radiography) indicates treatment for
pneumonia [22]. The UPSS variables will be scored in
the participating centers on each day a pulmonary radi-
ography has been performed. At the end of the trial, all
chest radiographs will be reassessed by one blinded and
independent radiologist. These scores will be used to de-
termine the diagnosis of pneumonia in the context of
this trial (Table 1).
Secondary endpoints
To evaluate the effect of IMT on respiratory muscle
function and lung function, participants will undergo
measurements at five time points (baseline (T0), the day
before surgery (T1), and during hospital stay on postop-
erative day 3 (T2), day 6 (T3), and day 9 (T4) (Figure 1)).
Forced expiratory volume in 1 second (FEV1) and forced
vital capacity (FVC) are assessed using a portable spirom-
eter. Respiratory muscle function will be evaluated using
maximal inspiratory pressure (Pimax) and inspiratory muscle
endurance (Piend). Pimax is measured at the mouth with a
forceful inspiratory maneuver at residual volume. To
measure Piend patients will be asked to breathe against an
inspiratory load of 70% Pimax until task failure (with a
PREPARE
Usual care
Surgery
T2, T3, T4
Discharge
T1T0
Baseline
measurement
Follow-up
measurement
Randomization
Hospital admissionRecovery period
Follow-up
measurementsInformed consent
Chemo radiation
Figure 1 Flowchart of PREPARE procedures.
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baseline). All measurements are performed in the seated
position.
To determine an effect of IMT on quality of life (QoL)
the EuroQol-5D and the SF-12 are assessed at baseline and
4 weeks after surgery. Postoperative pulmonary complica-
tions other than pneumonia are scored postoperatively (for
example, positive sputum cultures) as well as other postop-
erative complications (anastomotic leakage, chylus leakage,
wound infection, cardiac complications, sepsis, vocal cord
paralysis, critical illness polyneuropathy).
Other secondary endpoints are in-hospital mortality,
length of postoperative hospital stay (starting on the day of
surgery), mechanical ventilation time (number of hours
spent on the mechanical ventilator during and directly fol-
lowing the primary surgery), and number of re-intubations.
Other outcome measures
The following variables will be obtained from the patients’
medical records: discharge location (home, rehabilitation
center, nursing home, other hospital, hospice), operation
details (duration, location, technique, anastomosis, single/
double lung ventilation, use of mini-tracheal cannula, blood
loss, re-operation), mechanical ventilation details (duration,
re-intubation), tumor type, Mandard score (tumorregression grade), classification of malignant tumors
(TNM score), and date of first postoperative mobilization
(active, standing aid, passive lift).
Education and monitoring
All involved healthcare providers are well informed
about the study procedures. Surgeons and specialized
nurses providing the initial information about the PRE-
PARE trial are personally informed about the aims and
procedures of the study and their tasks within the trial by
the coordinating researcher. The research group organized
an afternoon meeting where the local assessors and PTs
attended practical workshops about the procedures and
use of all equipment. Additional written information is
provided as well. Study procedures will be monitored by
an independent monitor in the coordinating center and by
the coordinating researcher in the participating centers
during multiple monitoring visits (at the start of the trial,
after the first three completed patients, after 1 year, and at
the end of the trial).
Sample size calculation
Sample size is calculated based on an expected reduction
of 50% on the incidence of postoperative pneumonia [13].
Assuming a 30% incidence of postoperative pneumonia
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significance level of 0.05 and a power of 80%, 118 patients
are required in each arm [2,15,23]. Taking into account a
5% in-hospital mortality rate after surgery, approximately
124 patients per arm need to be included (248 patients
in total).
Statistical analyses
Data analyses will be performed in accordance with the
intention to treat principle. IBM SPSS statistics software
(version 20 or higher) will be used for data analyses. A
two-sided P value of less than 0.05 is regarded to be sta-
tistically significant. Analyses will be adjusted for center.
Literature shows that the odds ratio (OR) can be inter-
preted as relative risk (RR) when the incidence of the
outcome is < 10%. When the incidence is high, the OR
can overestimate the RR [24-26]. Therefore, analyses of
dichotomous variables will be performed using logistic
regression analysis when the incidence is ≤ 10% and with
Log-binomial regression analysis in the case of an incidence
of > 10%. The incidence of pneumonia will be compared
between the two groups and results will be presented as
OR or RR with a 95% confidence interval (CI). The risk dif-
ference and numbers needed to treat will also be calculated
when significant differences are found between groups.
For the continuous secondary outcome measures dur-
ation of mechanical ventilation and length of stay (ICU
and total), survival analysis (Cox proportional hazards re-
gression model) will be used to determine differences in
time to extubation and discharge. For the categorical sec-
ondary outcome measures other pulmonary complications
and in-hospital mortality the OR or RR will be calculated.
Other outcomes (for example, lung function, respiratory
muscle function, quality of life) will be compared be-
tween groups using linear regression for parametric
data or the Mann–Whitney U Test for non-parametric
data. To determine differences between time points in
lung function and respiratory muscle function, results will
be analyzed using the repeated measurements method
(General Linear Modeling Repeated Measures). In case of
missing measurements or covariates, multiple imputations
will be performed.
Discussion
The high incidence of pneumonia has large impact on
postoperative outcomes after esophageal resection. Mor-
tality rates are significantly higher compared to patients
without pneumonia (20% versus 3%) [6] and the use of
healthcare is substantially increased by extended duration
of hospital stay associated with increased healthcare costs
[5,7,8]. Furthermore, postoperative complications have a
negative influence on long-term quality of life [27,28]. Less
invasive surgical techniques attribute significantly to de-
creasing this high impact complication which is of highclinical relevance [4]. Preoperative IMT resulted in a re-
duction of 50% of postoperative pneumonia in cardiac sur-
gery patients and might be a promising intervention to
further reduce the incidence of postoperative pneumonia
after esophageal resection [13]. The PREPARE study is the
first multicenter RCT investigating the effect of this inter-
vention in esophageal resection candidates.
Methodological decisions of the PREPARE trial are
compared with strengths and weaknesses of other stud-
ies (since 2000) investigating the effect of preoperative
IMT (Table 2).
The PREPARE trial is the first study investigating the
effect of preoperative IMT in a multicenter design. Des-
pite increasing numbers of people with esophageal can-
cer, the number of patients undergoing esophageal
resection surgery per surgical center are relatively low.
To guarantee enough statistical power without the neces-
sity of including patients for several years, a multicenter
design was inevitable. The benefit of a multicenter design
is that it optimizes external validity of the study allowing
better generalization of the results. Furthermore, when
IMT proves to be successful, information and practical ex-
perience of the intervention is already spread in several
hospitals making implementation of IMT in routine care
easier. The disadvantage of a multicenter trial is the hand-
ling with differences in daily care procedures. Every par-
ticipating center has its own surgical and physical therapy
protocol making the usual care in every center unique.
However, by stratifying and randomizing per center, these
differences in usual care will be evenly divided between
both groups. Therefore the benefits of a multicenter ap-
proach weigh up to the disadvantages.
Besides the question whether a preoperative IMT pro-
gram results in lower incidence of postoperative pneumo-
nia, it is also relevant to investigate the causal mechanism
of how IMT results in less pneumonia. When IMT is ap-
plied in the preoperative phase it may prevent pulmonary
complications by decreasing the postoperative imbalance
between increased ventilatory demand and decreased
ventilatory capacity. The PREPARE protocol therefore
included postoperative follow-up measurements of re-
spiratory muscle and lung function, like the study of
Dettling et al. [15]. The measurements will show whether
the effects of preoperative IMT are still present in the
postoperative phase and provide data for exploratory ana-
lyses on the possible working mechanism of how IMT
may prevent PPCs.
The PREPARE study is the only study reporting a
priori sample size calculation, and is unique in esopha-
geal resection candidates with sufficient statistical power
to show reductions in pneumonia events. All esophageal
resection candidates are included in the PREPARE trial
without considering individual risk for PPCs since at
this point little is known about which patients will
Table 2 Overview of preoperative inspiratory muscle training studies
PREPARE trial Dettling [15] Agrelli [29] Hulzebos [13] Savci [30] Dronkers [16] Barbalho-Moulim [31] Kulkarni [32]
Study population Esophageal resection Esophageal
resection
Esophageal
resection
Cardiac surgery Cardiac
surgery
Upper abdominal
surgery
Open bariatric surgery Major abdominal
surgery
Number of (anticipated)
included patients
(248) 83 20 279 43 20 22 80
Sample size calculation + - - - - - - -
Randomization Individual - - Individual Individual Individual Individual Individual
Control group without IMT + + - + + + + +
Pilot-study - + + - - + - +
Blinding Primary and secondary
outcomes
- - Primary outcome - Primary outcome - -
Multicenter + - - - - - - -
Stratification Center and surgical
technique
- - - - - - -
Pulmonary risk stratification - - - + - + - -
Intervention
Duration of preoperative IMT 2-6 weeks 2 weeks 4 weeks > 2 weeks 5 days > 2 weeks 2-4 weeks 2 weeks
Supervised training sessions 1 1/week 1/week 1/week 5 sessions 1/week 1/week 1/week
High intensity program
(≥ 60% MIP)
+ - - - - - - -
Outcome
PPCs + + - + - + - -
Respiratory muscle function
(pre-/postoperative)
+/+ +/+ +/− +/− +/+ +/− +/+ +/+
Lung function
(pre-/postoperative)
+/+ −/− +/− −/− +/+ −/− +/+ +/+
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trast with two earlier studies who selected candidates
for preoperative IMT based on a risk score for PPCs
[13,16].
IMT is a simple intervention that is well tolerated by
patients [33]. The researchers have chosen a home-
based IMT program with guidance from a distance using
weekly telephone consultations. This deviation of the
other protocols where one training session a week is su-
pervised (see Table 2) was chosen to decrease the burden
for the patients and to increase inclusion rates. Patients
often have to travel 30 minutes or more to reach the
hospital. The standpoint of the PREPARE trial is that the
intervention should fit in with daily care practice and
with daily life of the patient. A weekly in-hospital phys-
ical therapy session of no more than 30 minutes (one
high intensity training sessions of 30 breaths will take no
more than 5 minutes) will discourage patients to partici-
pate in the trial or in an IMT program in general. Based
on years of experience in guiding patients in performing
their home-based IMT program, the PREPARE team pre-
sumes that clear instructions at baseline, an instruction
video and the weekly telephone consultations should be
sufficient to guide the patients and to monitor patient
compliance. Furthermore, the memory of the digital in-
spiratory muscle trainer (POWERbreathe K3-series) en-
ables the PTs to compare the last 36 trainings sessions
with the recorded data in the patient diary which enables
a supplementary check on patient compliance and ad-
equate adjustment of the training load.
The PREPARE study is the first to use a high intensity
training protocol in the preoperative phase. Based on
promising results in healthy adults [34] and patients
with COPD [14] the PREPARE team chose to use a high
intensity training program proposed by Bailey et al. [18].
The protocol of 30 breaths twice daily is easy to perform
unsupervised and will take only a few minutes per train-
ing session, possibly resulting in higher compliance to
this specific training. The broad range of 5 to 200 cm
H2O of the inspiratory load of the POWERbreathe
equipment makes it possible to set the load for each in-
dividual. Other advantages of the POWERbreathe equip-
ment is the tapered flow resistive loading, the gradually
increasing load during the first three inspirations, the re-
cording of the average load, average power, average vol-
ume, and training index (training effectiveness).
In conclusion, this multicenter RCT will investigate
the hypothesis that preoperative IMT is associated with
reduced postoperative pneumonia following esophageal
resection. The PREPARE trial differentiates from other
studies in its design and robustness.
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